The contemporary investigation of ibogaine therapy represents one of the most compelling and heavily debated frontiers in modern psychopharmacology, addiction medicine, and neurobiology. Across an extensive international landscape spanning the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland, clinical researchers and healthcare specialists are re-evaluating how naturally […]